Categories: News

GAC Models Lead China Automotive Resale Value Rankings, Reinforcing the Strength of “Quality GAC”

BEIJING, Feb. 2, 2026 /PRNewswire/ — On January 27, the China Automobile Dealers Association and Jingzhengu, released the 2025 China Automotive Resale Value ranking Report. GAC’s brands AION and GAC achieved outstanding results, with the M8 and GS8 topping resale value rankings in their respective segments, demonstrating the strong market recognition and value of “Quality GAC.”

- Advertisement -

As competition in China’s automotive market intensifies, resale value has become a critical measure of a vehicle’s long-term value and reputation. Jointly issued by the China Automobile Dealers Association and Jingzhengu, the annual resale value report has steadily enhanced its assessment methodology, aiming to establish “resale value” as a “shared metric” among manufacturers, distributors, consumers, and policymakers. It not only reflects a vehicle’s value retention, but also meaningfully influences consumer purchase decisions.

- Advertisement -

GAC led the rankings with a commanding advantage, ranking first among Chinese brands in three-year resale value. Several models achieved top positions across key segments. In the MPV segment, the M8 ranked first among Chinese-brand MPVs in three-year resale value, with the M6 placed third. The E8 and E9 took the top two spots in one-year resale value for Chinese-brand plug-in hybrid MPVs, underlining GAC’s expertise and market credibility in the MPV sector. In the SUV segment, the GS8 ranked first among Chinese-brand mid-size SUVs for three-year resale value, while the GS3 EMZOOM placed third in the compact SUV category. Meanwhile, the EMPOW and GA6 secured third and fourth place respectively in the compact and mid-size sedan categories, demonstrating comprehensive coverage of mainstream consumer segments and catering to diverse user value needs.

- Advertisement -

AION also demonstrated strong residual value performance. The AION RT ranked second in one-year resale value among pure electric compact cars, while the AION Y placed third in three-year resale value for pure electric compact SUVs. Backed by the world’s only NEV “Lighthouse Factory,” AION ensures products with “zero defects and zero faults.” In 2025, it achieved the top ranking in China’s new energy vehicle quality for the third consecutive year, maintaining leading resale value and customer satisfaction.

- Advertisement -

These achievements reflect GAC’s strong manufacturing expertise and commitment to quality, as well as broad market recognition. Looking ahead, GAC will continue leveraging technology and a user-centric approach to enhance competitiveness, deliver higher-value mobility solutions, and lead the high-quality development of China’s automotive industry.

- Advertisement -

Photo – https://mma.prnewswire.com/media/2874205/image.jpg

- Advertisement -

View original content:https://www.prnewswire.co.uk/news-releases/gac-models-lead-china-automotive-resale-value-rankings-reinforcing-the-strength-of-quality-gac-302675821.html

- Advertisement -

Recent Posts

Dassault Systmes CEO Pascal Daloz becomes also Chairman of the Board of Directors of Dassault Systmes

Press ReleaseVELIZY-VILLACOUBLAY, France — February 21, 2026 Dassault Systèmes’ CEO Pascal Daloz becomes also Chairman…

2 hours ago

Weaviate Launches Agent Skills to Empower AI Coding Agents

Amsterdam, Netherlands, Feb. 21, 2026 (GLOBE NEWSWIRE) -- February 20, 2026 – Weaviate, the leading…

2 hours ago

Seedance2ai.online Launches All-in-One Seedance 2.0 Video Creation Platform With Free Tier for Global Creators

LOS ANGELES, CA, Feb. 21, 2026 (GLOBE NEWSWIRE) -- Seedance2ai.online today announced the public launch…

2 hours ago

Amdavad 2030 Opens Doors to Global Business Opportunities

West Midlands Mayor Leads Strategic UK Delegation to Translate Sporting Ambition into Long-Term Economic PartnershipsAHMEDABAD,…

6 hours ago

Thermobalancing therapy emerges as drug-free option for BPH, chronic prostatitis, back pain and kidney stones

Oxford, UK, Feb. 21, 2026 (GLOBE NEWSWIRE) -- Therapeutic Dr Allen’s Devices are designed to…

7 hours ago

Eupraxia Pharmaceuticals Announces Closing of US$63.2 Million Public Offering Including Full Exercise of Underwriter Option

February 20, 2026 15:10 ET  | Source: Eupraxia Pharmaceuticals Inc. VICTORIA, British Columbia, Feb. 20,…

7 hours ago